Indoco Remedies receives USFDA approval for Rasagiline 0.5 mg and 1 mg tablets

Indoco Remedies has received the final approval for its Abbreviated New Drug Application (ANDA) for Rasagiline 0.5 mg and 1 mg tablets from the United States Food & Drug Administration (USFDA). Rasagiline is used for treatment of Parkinson's disease. The market size of this product in the US as per IMS 2018 data is US$ 105 million.

Powered by Capital Market - Live News